KEGG: ecz:ECS88_4215
Methodological Answer:
wecF catalyzes 4-α-L-fucosyltransferase activity. Antibody utility depends on:
Conformational Sensitivity: Use non-denaturing PAGE to preserve epitopes, as denatured wecF may lose enzymatic activity and antibody binding .
Enzyme-Substrate Complexes: Co-incubate with GDP-fucose substrate during immunoprecipitation to stabilize active conformations .
Quantitative WB: Normalize band intensity to activity measurements (HPLC-based fucose transfer assays) .
Linear epitope antibodies fail to inhibit activity, while conformational antibodies reduce fucosylation by 80% .
Methodological Answer:
Technical Artifacts:
Biological Variability:
Epitope Accessibility:
Methodological Answer:
Structural Studies:
Functional Blocking:
Pathogenicity Studies:
wecF-dependent fucosylation enhances bacterial adhesion to intestinal epithelial cells (EC50 reduction from 10 μM to 2 μM with antibody pretreatment) .
Methodological Answer:
Spectral Compatibility: Pair wecF-Alexa488 with lectins (e.g., UEA-1-Alexa647) for dual-channel IF .
Cross-Adsorption: Pre-clear antibody against immobilized lectins to eliminate non-specific binding .
Quantitative Workflow:
| Probe Combination | Signal Crosstalk (%) | Resolution (nm) |
|---|---|---|
| wecF-A488 + UEA-1-A647 | <5% | 220 |
| wecF-A488 + WGA-A555 | 18% | 180 |
Methodological Answer:
Predictive Modeling:
Evolutionary Analysis:
Deep Mutational Scanning:
Epitope residues 128–145 (α-helix) show 90% conservation across Yersinia spp., making this region ideal for diagnostic applications .
Methodological Answer:
Stability Testing:
Lyophilization:
Freeze-Thaw Cycles:
| Cycles | WB Signal Intensity |
|---|---|
| 0 | 100% |
| 5 | 78% |
| 10 | 42% |